BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 12918062)

  • 1. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.
    Brusselmans K; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Int J Cancer; 2003 Oct; 106(6):856-62. PubMed ID: 12918062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
    Gupta S; Ahmad N; Nieminen AL; Mukhtar H
    Toxicol Appl Pharmacol; 2000 Apr; 164(1):82-90. PubMed ID: 10739747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
    Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
    Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
    Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
    Hastak K; Agarwal MK; Mukhtar H; Agarwal ML
    FASEB J; 2005 May; 19(7):789-91. PubMed ID: 15764647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells.
    Hussain T; Gupta S; Adhami VM; Mukhtar H
    Int J Cancer; 2005 Feb; 113(4):660-9. PubMed ID: 15455372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate.
    Paschka AG; Butler R; Young CY
    Cancer Lett; 1998 Aug; 130(1-2):1-7. PubMed ID: 9751250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel inhibitors of fatty-acid synthase from green tea (Camellia sinensis Xihu Longjing) with high activity and a new reacting site.
    Zhang R; Xiao W; Wang X; Wu X; Tian W
    Biotechnol Appl Biochem; 2006 Jan; 43(Pt 1):1-7. PubMed ID: 15943584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
    Wang YC; Bachrach U
    Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis induction by epigallocatechin gallate involves its binding to Fas.
    Hayakawa S; Saeki K; Sazuka M; Suzuki Y; Shoji Y; Ohta T; Kaji K; Yuo A; Isemura M
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1102-6. PubMed ID: 11478767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea constituent (--)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells.
    Berger SJ; Gupta S; Belfi CA; Gosky DM; Mukhtar H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):101-5. PubMed ID: 11594758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R; Sasaki K; Yoshida K
    Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green tea constituent (-)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways.
    Kuo PL; Lin CC
    J Biomed Sci; 2003; 10(2):219-27. PubMed ID: 12595758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-gallate and bicalutamide cause growth arrest and apoptosis in NRP-152 and NRP-154 prostate epithelial cells.
    Morrissey C; Brown M; O'Sullivan J; Weathered N; Watson RW; Tenniswood M
    Int J Urol; 2007 Jun; 14(6):545-51. PubMed ID: 17593102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate.
    Garbisa S; Sartor L; Biggin S; Salvato B; Benelli R; Albini A
    Cancer; 2001 Feb; 91(4):822-32. PubMed ID: 11241252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer.
    Crous-Masó J; Palomeras S; Relat J; Camó C; Martínez-Garza Ú; Planas M; Feliu L; Puig T
    Molecules; 2018 May; 23(5):. PubMed ID: 29751678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of prostate cancer cells by epigallocatechin gallate in the presence of Cu2+.
    Yu HN; Yin JJ; Shen SR
    J Agric Food Chem; 2004 Feb; 52(3):462-6. PubMed ID: 14759133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
    Puig T; Vázquez-Martín A; Relat J; Pétriz J; Menéndez JA; Porta R; Casals G; Marrero PF; Haro D; Brunet J; Colomer R
    Breast Cancer Res Treat; 2008 Jun; 109(3):471-9. PubMed ID: 17902053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea extract (epigallocatechin-3-gallate) reduces efficacy of radiotherapy on prostate cancer cells.
    Thomas F; Holly JM; Persad R; Bahl A; Perks CM
    Urology; 2011 Aug; 78(2):475.e15-21. PubMed ID: 21676444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.